“This is a first step to help us better understand their mechanisms and potential therapeutic applications”

Content of the article

Numinus has expanded the list of substances it is legally authorized to study.

Advertisement 2

Content of the article

The Vancouver-based company has been approved by Health Canada to research and study ayahuasca, which contains DMT, and San Pedro cactus, which contains mescaline.

“This is a first step to help us better understand their mechanisms and potential therapeutic applications,” said Sharan Sidhu, Chief Scientist and CEO of Numinus Bioscience, said in a press release.

  1. A natural psychedelic, psilocybin is produced by over 200 species of mushrooms.  PHOTO BY GETTY IMAGES/ISTOCKPHOTO

    What Canada’s Special Access Program means for patients and doctors

  2. TheraPsil says the decision will affect more than a thousand healthcare professionals who were on a waiting list for the organization's training program and

    Health Canada denies medical professionals access to psilocybin for training purposes

  3. Physicians will be able to request restricted access to drugs for patients with treatment-resistant or life-threatening conditions, and each request will be assessed on a case-by-case basis.

    Canadian doctors can now request patient access to restricted drugs, including MDMA and psilocybin

The company has previously been licensed to work with psilocybin, LSD, MDMA and ketamine and its reseller license allows Numinus to own, test, produce, assemble, sell, export and deliver a range of psychedelic compounds.

Advertisement 3

Content of the article

Acknowledging that these substances have long had traditional and ceremonial uses, Payton Nyquvest, CEO and Founder of Numinus, said the latest amendments “honor and build on these practices while allowing us to do new clinical research and deepen the body of scientific data for large-scale development”. and better public access to life-saving therapies.

In January, Numinus was included in a Health Canada list of companies that can supply psilocybin to applicants approved through the Special Access Program (SAP).

Health Canada amended the Special Access Program (SAP) earlier this year, allowing physicians to request patient access to restricted drugs and psychedelic treatments like psilocybin and MDMA-assisted therapy, on a case-by-case basis. per case.

Advertisement 4

Content of the article

The news was first celebrated in some corners, but supporters say it doesn’t go far enough.

Spencer Hawkswell, CEO of TheraPsil, a British Columbia-based nonprofit that helps Canadians access psychedelic-assisted psychotherapy, previously said Growth Op that the changes to the SAP are a “stop-gap measure”.

“We have been shouting in the streets for a few years that it is too little too late. But it really is. So as happy as some of us are, we need more, and medical regulations are that answer,” he said.

The organization is currently fundraising to support a potential legal challenge after Health Canada informed TheraPsil last month that it planned to deny medical professionals Section 56 exemptions to access psilocybin for training purposes.

Advertisement 5

Content of the article

According to the organization, 86 health care practitioners enrolled in TheraPsil’s psilocybin therapy training program received “intent to refuse” letters. TheraPsil says professional education on psilocybin is desperately needed as more and more Canadians choose this treatment option.

The organization says it has more than 1,500 patients on its waiting list and only 19 practitioners have received exemptions to complete its training program.

“[Psilocybin] is not just a drug that you give to a patient,” Hawkswell said. Growth Op in January. “It’s drug therapy. We need trained healthcare practitioners to be there to hold space and provide therapy for these patients.

To subscribe to weekend dispensarya weekly newsletter from The GrowthOp.

Advertisement 1


Postmedia is committed to maintaining a lively yet civil discussion forum and encourages all readers to share their views on our articles. Comments can take up to an hour to be moderated before appearing on the site. We ask that you keep your comments relevant and respectful. We have enabled email notifications. You will now receive an email if you receive a reply to your comment, if there is an update to a comment thread you follow, or if a user follows you comments. Visit our Community Rules for more information and details on how to adjust your E-mail settings.


Canadian company Evermore Capital is committed to supporting the people of Ukraine


The Weather Network - Start your spring cleaning with eco-responsible Canadian products

Check Also